Doxorubicin—an agent with multiple mechanisms of anticancer activity

M Kciuk, A Gielecińska, S Mujwar, D Kołat… - Cells, 2023 - mdpi.com
Doxorubicin (DOX) constitutes the major constituent of anti-cancer treatment regimens
currently in clinical use. However, the precise mechanisms of DOX's action are not fully …

[HTML][HTML] Selenium stimulates the antitumour immunity: Insights to future research

A Razaghi, M Poorebrahim, D Sarhan… - European Journal of …, 2021 - Elsevier
Selenium is an essential trace element for regulating immune functions through redox-
regulating activity of selenoproteins (eg glutathione peroxidase), protecting immune cells …

Construction of Fe-doped ZIF-8/DOX nanocomposites for ferroptosis strategy in the treatment of breast cancer

Y Zhong, Z Peng, Y Peng, B Li, Y Pan… - Journal of Materials …, 2023 - pubs.rsc.org
Breast cancer has become one of the top five commonest causes of cancer death. The use
of ferroptosis to induce the generation of reactive oxygen species (ROS) in cancer cells …

Role of reactive oxygen species in cancer progression: molecular mechanisms and recent advancements

V Aggarwal, HS Tuli, A Varol, F Thakral, MB Yerer… - Biomolecules, 2019 - mdpi.com
Reactive oxygen species (ROS) play a pivotal role in biological processes and continuous
ROS production in normal cells is controlled by the appropriate regulation between the silver …

Activatable nanomedicine for overcoming hypoxia-induced resistance to chemotherapy and inhibiting tumor growth by inducing collaborative apoptosis and …

J Fu, T Li, Y Yang, L Jiang, W Wang, L Fu, Y Zhu… - Biomaterials, 2021 - Elsevier
Hypoxia has been firmly correlated to the drug resistance of solid tumors. Alleviation of
hypoxia by tumor reoxygenation is expected to sensitize the chemotherapy toward solid …

Cytotoxic mechanisms of doxorubicin at clinically relevant concentrations in breast cancer cells

RE Nicoletto, CM Ofner III - Cancer Chemotherapy and Pharmacology, 2022 - Springer
Doxorubicin (DOX) is a chemotherapeutic agent frequently used for the treatment of a variety
of tumor types, such as breast cancer. Despite the long history of DOX, the mechanistic …

Oxidative stress and cellular response to doxorubicin: a common factor in the complex milieu of anthracycline cardiotoxicity

D Cappetta, A De Angelis, L Sapio… - Oxidative medicine …, 2017 - Wiley Online Library
The production of reactive species is a core of the redox cycling profile of anthracyclines.
However, these molecular characteristics can be viewed as a double‐edged sword acting …

The role of flavonoids as a cardioprotective strategy against doxorubicin-induced cardiotoxicity: a review

RA Syahputra, U Harahap, A Dalimunthe, MP Nasution… - Molecules, 2022 - mdpi.com
Doxorubicin is a widely used and promising anticancer drug; however, a severe dose-
dependent cardiotoxicity hampers its therapeutic value. Doxorubicin may cause acute and …

[HTML][HTML] Apigenin ameliorates doxorubicin-induced renal injury via inhibition of oxidative stress and inflammation

Q Wu, W Li, J Zhao, W Sun, Q Yang, C Chen… - Biomedicine & …, 2021 - Elsevier
Background and objective Doxorubicin (DOX) is an anthracycline antitumor antibiotic widely
utilized in treating various tumors. Nevertheless, the toxicity of DOX toward normal cells …

Development of “smart” drug delivery systems for chemo/PDT synergistic treatment

M Yu, R Cao, Z Ma, M Zhu - Journal of Materials Chemistry B, 2023 - pubs.rsc.org
Although chemotherapy and photodynamic therapy (PDT) have been developed for fighting
cancer, the complex and heterogeneous nature of tumors makes it difficult for a single …